1. Home
  2. ABL vs CSTL Comparison

ABL vs CSTL Comparison

Compare ABL & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABL
  • CSTL
  • Stock Information
  • Founded
  • ABL 2004
  • CSTL 2007
  • Country
  • ABL United States
  • CSTL United States
  • Employees
  • ABL N/A
  • CSTL N/A
  • Industry
  • ABL Investment Managers
  • CSTL Medical Specialities
  • Sector
  • ABL Finance
  • CSTL Health Care
  • Exchange
  • ABL Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • ABL 723.0M
  • CSTL 848.1M
  • IPO Year
  • ABL N/A
  • CSTL 2019
  • Fundamental
  • Price
  • ABL $7.72
  • CSTL $27.53
  • Analyst Decision
  • ABL Strong Buy
  • CSTL Strong Buy
  • Analyst Count
  • ABL 4
  • CSTL 6
  • Target Price
  • ABL $14.38
  • CSTL $39.67
  • AVG Volume (30 Days)
  • ABL 443.3K
  • CSTL 314.0K
  • Earning Date
  • ABL 11-07-2024
  • CSTL 11-04-2024
  • Dividend Yield
  • ABL N/A
  • CSTL N/A
  • EPS Growth
  • ABL N/A
  • CSTL N/A
  • EPS
  • ABL N/A
  • CSTL 0.21
  • Revenue
  • ABL $102,407,324.00
  • CSTL $311,878,000.00
  • Revenue This Year
  • ABL $70.90
  • CSTL $51.36
  • Revenue Next Year
  • ABL $65.20
  • CSTL N/A
  • P/E Ratio
  • ABL N/A
  • CSTL $130.87
  • Revenue Growth
  • ABL 77.68
  • CSTL 62.43
  • 52 Week Low
  • ABL $7.07
  • CSTL $16.97
  • 52 Week High
  • ABL $13.25
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • ABL 41.66
  • CSTL 38.11
  • Support Level
  • ABL $7.63
  • CSTL $26.30
  • Resistance Level
  • ABL $8.09
  • CSTL $32.57
  • Average True Range (ATR)
  • ABL 0.33
  • CSTL 1.63
  • MACD
  • ABL 0.01
  • CSTL -0.32
  • Stochastic Oscillator
  • ABL 42.25
  • CSTL 19.52

About ABL Abacus Life Inc.

Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Share on Social Networks: